Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span.

Autor: Schrager, Matthew A., Roth, Stephen M., Ferrell, Robert E., Metter, E. Jeffrey, Russek-Cohen, Estelle, Lynch, Nicole A., Lindle, Rosemary S., Hurley, Ben F.
Předmět:
Zdroj: Journal of Applied Physiology; Dec2004, Vol. 97 Issue 6, p2176-2183, 8p, 4 Charts, 2 Graphs
Abstrakt: The influence of insulin-like growth factor-2 (IGF2) genotype on total body fat-free mass (FFM), muscle strength, and sustained power (SP) was evaluated repeatedly at ∼2-yr intervals in two cohorts from the Baltimore Longitudinal Study of Aging. Cohort 1 was comprised of 94 men tested for isometric grip strength and SP. Cohort 2 was comprised of 246 men and 239 women tested for total body FFM and isokinetic peak torque. Subjects were retrospectively genotyped for the IGF2 gene's Apal polymorphism. Differences between genotype groups for total FFM, strength, and SP at first visit, at peak age (35 yr), at age 65, and across the adult age span were analyzed using either two-sample t-tests or mixed-effects models, depending on the specific comparisons made. Isokinetic arm strength at the time of first visit was lower in A/A men than in GIG men (P < 0.05). Compared with G/G women, A/A women had lower total body FFM, lower isokinetic arm and leg strength at the time of first visit, and lower values at age 35 (all P < 0.05) for these muscle phenotypes. Furthermore, this difference between the genotype groups was maintained at age 65 and across the adult age span (P < 0.05). No genotype-associated differences in rates of loss of grip strength or SP were found in cohort 1. These results from cohort 2 support the hypothesis that variation within a gene known to influence developing muscle affects muscle mass and muscle function in later life. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index